The case for repatriating the U.S. drug supply EP26 Medically Necessary
Shortages of many generic drugs have plagued the U.S. health system for decades. The leading cause of drug shortages is quality issues at manufacturing plants, which are mostly located overseas. Some experts argue that bringing pharmaceutical production back to the U.S. will help companies and regulators better monitor manufacturing and avoid issues.\nFollow Medically Necessary on Apple Podcasts\nFollow Medically Necessary on Spotify\nMore FreightWaves Podcasts\n\nLearn more about your ad choices. Visit megaphone.fm/adchoices